IP Library Granted Patent US 11,045,353
Granted Patent B2
US 11,045,353 · App. 15/975,934 · Granted Jun 29, 2021

Ophthalmic surgical system with infusion fluid and substance delivery through an infusion cannula

Inventor: Paul R. Hallen (Colleyville, TX)
Assignee: Alcon Inc.
A61F9/00736A61M5/142A61M5/1407A61M5/1408A61M2202/04A61M2205/3337A61M2205/50A61M2205/502A61M2210/0612
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,045,353
App. No.
15/975,934
Granted
Jun 29, 2021
Kind
B2
Abstract

In some embodiments, an ophthalmic cassette valve may be configured to control flow of an infusion fluid and an ophthalmic substance (e.g., ophthalmic drug, a retina patch material, or an ophthalmic dye) to an infusion cannula. The valve may be configured to provide an alternating or mixed flow of the infusion fluid and the ophthalmic substance to the infusion cannula. In some embodiments, the cassette may include multiple substance chambers with different substances. The cassette may also include a one or more valves to control the flow to the infusion fluid (e.g., on/off for each of the substances and infusion fluid and/or a ratio of the substances and infusion fluid).

Claims (42)

1. A cassette, comprising:

a cassette infusion connector configured to receive infusion fluid from an infusion fluid system;

a substance chamber comprising a substance;

at least one valve coupled to the cassette infusion connector and the substance chamber;

wherein the at least one valve is configured to control flow of the infusion fluid from the cassette infusion connector and control flow of the substance from the substance chamber, wherein a position of the valve controls a ratio of the substance to infusion fluid flowing through the valve to create a mixed flow;

wherein the mixed flow from the at least one valve is provided to an infusion cannula fluidically coupled to the cassette.

2. The cassette of claim 1 , wherein the substance in the substance chamber is an ophthalmic drug, a retina patch material, or an ophthalmic dye.

3. The cassette of claim 1 , wherein the at least one valve is also configured to provide an alternating flow of the infusion fluid or the substance to the infusion cannula.

4. The cassette of claim 1 , wherein the substance chamber is a first substance chamber comprising a first substance and wherein the cassette further comprises a second substance chamber comprising a second substance.

5. The cassette of claim 4 , wherein the at least one valve is configured to control flow of the infusion fluid from the cassette infusion connector, the first substance from the first substance chamber and the second substance from the second substance chamber to provide an alternative or mixed flow to the infusion cannula.

6. The cassette of claim 4 , wherein the at least one valve comprises:

a first valve configured to control flow of the infusion fluid from the cassette infusion connector,

a second valve configured to control flow of the first substance from the first substance chamber, and

a third valve configured to control flow of the second substance from the second substance chamber,

wherein at least two of the first, second, and third valves provide an alternative or mixed flow to the infusion cannula.

7. The cassette of claim 4 , wherein the at least one valve consists of one valve, and wherein the one valve is coupled to the cassette infusion connector, the first substance chamber, and the second substance chamber to control flow of the infusion fluid, the first substance, and the second substance to the infusion cannula.

8. The cassette of claim 1 , further comprising a control mechanism configured to receive input from a user, wherein the at least one valve is controlled by the control mechanism.

9. The cassette of claim 1 , wherein the substance and infusion fluid are mixed as they travel through the valve and not before the substance and the infusion fluid enter the valve.

10. A system, comprising:

a source of infusion fluid;

a cassette, comprising:

a cassette infusion connector configured to receive infusion fluid from the source of infusion fluid;

a substance chamber comprising a substance;

at least one valve coupled to the cassette infusion connector and the substance chamber, wherein the valve is configured to control flow of an infusion fluid from the cassette infusion connector and the substance from the substance chamber to provide a mixed flow to an infusion cannula, wherein a position of the valve controls a ratio of the substance to infusion fluid flowing through the valve to create the mixed flow; and

a control mechanism configured to receive input from a user, wherein the at least one valve is controlled by the control mechanism to adjust the ratio according to the received input from the user.

11. The system of claim 10 , wherein the substance in the substance chamber is an ophthalmic drug, a retina patch material, or an ophthalmic dye.

12. The system of claim 10 , wherein the at least one valve is also configured to provide an alternating flow of the infusion fluid or the substance to the infusion cannula.

13. The system of claim 10 , wherein the substance chamber is a first substance chamber comprising a first substance and wherein the cassette further comprises a second substance chamber comprising a second substance.

14. The system of claim 13 , wherein the at least one valve is configured to control flow of the infusion fluid from the cassette infusion connector, the first substance from the first substance chamber and the second substance from the second substance chamber to provide an alternative or mixed flow to the infusion cannula.

15. The system of claim 13 , wherein the at least one valve comprises:

a first valve configured to control flow of the infusion fluid from the cassette infusion connector,

a second valve configured to control flow of the first substance from the first substance chamber, and

a third valve configured to control flow of the second substance from the second substance chamber,

wherein at least two of the first, second, and third valves provide an alternative or mixed flow to the infusion cannula.

16. The system of claim 13 , wherein the at least one valve consists of one valve, and wherein the one valve is coupled to the cassette infusion connector, the first substance chamber, and the second substance chamber to control flow of the infusion fluid, the first substance, and the second substance to the infusion cannula.

17. The system of claim 10 , wherein the substance and infusion fluid are mixed as they travel through the valve and not before the substance and the infusion fluid enter the valve.

18. A method, comprising:

provide infusion fluid through an infusion line to an infusion cannula;

receiving a command to control a valve coupled to a substance chamber; and

activate the valve to release a substance from the substance chamber into the infusion line to the infusion cannula, wherein activating the valve comprises controlling a position of the valve to control a ratio of the substance to infusion fluid flowing through the valve to create a mixed flow.

19. The method of claim 18 , further comprising deactivating the infusion fluid flow to the infusion cannula prior to releasing the substance from the substance chamber and then deactivating the release of the substance prior to re-providing the infusion fluid to result in an alternating flow of the infusion fluid or the substance to the infusion cannula.

20. The method of claim 18 , wherein the substance and infusion fluid are mixed as they travel through the valve and not before the substance and the infusion fluid enter the valve.

Assignments (3)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2018
From: HALLEN, PAUL R.
To: ALCON LABORATORIES, INC.
Reel/Frame 045768/0754 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2018
From: ALCON LABORATORIES, INC.
To: NOVARTIS AG
Reel/Frame 045768/0815 →